Pieris Pharmaceuticals In...

NASDAQ: PIRS · Real-Time Price · USD
13.60
-2.51 (-15.58%)
At close: Dec 13, 2024, 10:00 PM

Pieris Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.74 -0.67 -2.47 -5.63
PEG Ratio
0.03 0.02 0.07 3.34
PS Ratio
n/a 0.38 2.98 7.77
PB Ratio
0.48 0.61 2.76 4.81
P/FCF Ratio
-2.79 -0.3 -1.27 -28.34
P/OCF Ratio
-2.79 -0.3 -1.29 -31.85
OCF/S Ratio
n/a -1.26 -2.31 -0.24
Debt / Equity Ratio
n/a n/a 0.47 0.27
Quick Ratio
7.33 3.24 2.01 2.52
Current Ratio
7.33 3.24 2.01 2.52
Asset Turnover
n/a 1.11 0.27 0.20
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.28 -0.92 -1.12 -0.85
Return on Assets
-0.2 -0.63 -0.33 -0.28
Return on Invested Capital
n/a -1.11 -0.68 -0.47
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a 0.02 0.89 0.92
Net Profit Margin
n/a -0.57 -1.21 -1.38
Pretax Profit Margin
n/a -0.57 -1.28 -1.46
Operating Profit Margin
n/a -0.7 -1.68 -1.65
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a -0.53 -1.18 -1.38